Compare YieldMax NVDA Option Income Strategy ETF (NVDY) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
YieldMax NVDA Option Income Strategy ETF vs Health Care Select Sector SPDR Fund — how do they compare? YieldMax NVDA Option Income Strategy ETF trades at $12.57 (market cap $1.45B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 30× YieldMax NVDA Option Income Strategy ETF's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, YieldMax NVDA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold YieldMax NVDA Option Income Strategy ETF for 43 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| NVDY | XLV | |
|---|---|---|
Market Cap | $1.45B | $43.48B |
Volume | 1,943,739 | 11,121,431 |
Sector | Income / Options Overlay | — |
52-Week High | $17.21 | $175.68 |
52-Week Low | $11.58 | $141.95 |
Typical Hold Time | 43 Days | 100 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVDY, the YieldMax NVDA Option Income Strategy ETF, trades at $12.62, down 3.0% today, amid a bearish technical signal. The fund generates income via options on NVIDIA stock, with recent weekly dividends averaging around $0.10. However, technical indicators show selling pressure, with moving averages and ADX signaling bearish momentum, while oscillators remain neutral. Recent news highlights concerns over NAV erosion and capped upside despite high distribution yields.
The outlook is cautious due to structural limitations on capital appreciation and reliance on NVIDIA's volatility for income. Risks include potential NAV decay from the options strategy and sensitivity to changes in implied volatility. Analyst sentiment is neutral to bearish, with downgrades citing diminished income potential. Investors seeking NVIDIA exposure may find direct ownership more favorable for growth.
XLV trades at $168.16, down 0.39% on the day, with technical indicators showing a bearish bias as the ETF tests key support levels. The healthcare ETF maintains a competitive 0.08% expense ratio and offers diversified exposure to 60 S&P 500 healthcare stocks. Recent options activity shows increased put volume, suggesting some investor caution despite the sector's defensive characteristics.
The healthcare sector's defensive nature and potential Fed rate hike resilience provide stability, though technical weakness and political volatility around midterm elections present near-term risks. XLV's low-cost structure and broad diversification make it an efficient vehicle for healthcare exposure, but sector-specific headwinds like drug trial failures warrant monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About YieldMax NVDA Option Income Strategy ETF
NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
